Explore

Trendline Trendline
SquareMind Secures $18M to Advance Dermatology Robotics Platform for Skin Cancer Detection

SquareMind Secures $18M to Advance Dermatology Robotics Platform for Skin Cancer Detection

SquareMind Secures $18M to Advance Dermatology Robotics Platform for Skin Cancer Detection
Trendline Trendline
Bruin Biometrics Innovates Pressure Ulcer Detection with New Scanning Device

Bruin Biometrics Innovates Pressure Ulcer Detection with New Scanning Device

Bruin Biometrics Innovates Pressure Ulcer Detection with New Scanning Device
Rapid Read Rapid Read
Innovative Device Targets $27 Billion Pressure Ulcer Problem in Healthcare

Innovative Device Targets $27 Billion Pressure Ulcer Problem in Healthcare

Bruin Biometrics Inc., a UCLA spin-off, has developed a scanning device called ProVizio to detect precursor conditions for pressure ulcers, a significant issue in healthcare costing up to $27 billion annually. The device, which has received FDA clearance, allows caregivers to identify potential pressure ulcers before they form, enabling early intervention. This technology is particularly crucial as pressure ulcers affect millions annually, with treatment costs reaching up to $70,000 per case. The device is primarily used in hospitals, skilled nursing facilities, and home-care settings, providing a proactive approach to managing pressure injuries.
Trendline Trendline
SquareMind Secures $18M to Launch Robotic Dermatology Platform in U.S. and Europe

SquareMind Secures $18M to Launch Robotic Dermatology Platform in U.S. and Europe

SquareMind Secures $18M to Launch Robotic Dermatology Platform in U.S. and Europe
Trendline Trendline
Holivita Unveils AI-Driven Health Platform to Enhance Preventive Care

Holivita Unveils AI-Driven Health Platform to Enhance Preventive Care

Holivita Unveils AI-Driven Health Platform to Enhance Preventive Care
Trendline Trendline
bioAffinity Technologies Initiates Study on CyPath Lung Technology for Asthma and COPD

bioAffinity Technologies Initiates Study on CyPath Lung Technology for Asthma and COPD

bioAffinity Technologies Initiates Study on CyPath Lung Technology for Asthma and COPD
Rapid Read Rapid Read
AI Model Predicts ADHD Risk in Children Using Electronic Health Records

AI Model Predicts ADHD Risk in Children Using Electronic Health Records

A study conducted by Duke University researchers has demonstrated the potential of artificial intelligence (AI) to predict the risk of Attention-Deficit/Hyperactivity Disorder (ADHD) in children years before a clinical diagnosis is typically made. By analyzing electronic health records (EHRs) of over 140,000 children, the AI model identifies patterns in developmental and behavioral markers that may indicate a future ADHD diagnosis. The model is particularly notable for its consistent accuracy across various demographics, including sex, race, ethnicity, and insurance status. This tool is designed to act as a 'clinical safety net,' ensuring that children at risk receive early evaluations and support during critical developmental periods.
Trendline Trendline
Azra AI Acquires Thynk Health to Enhance Cancer Care Coordination

Azra AI Acquires Thynk Health to Enhance Cancer Care Coordination

Azra AI Acquires Thynk Health to Enhance Cancer Care Coordination
Rapid Read Rapid Read
AI's Potential to Transform Medicine Hinges on Regulatory Frameworks

AI's Potential to Transform Medicine Hinges on Regulatory Frameworks

Artificial intelligence (AI) is increasingly being used in medicine, with one in three Americans turning to AI chatbots for medical advice. However, the lack of consistent regulation poses challenges. Some states, like New York, are considering strict regulations, while others, like California, are taking a more balanced approach. The federal government is also involved, with the FDA updating guidelines to allow AI tools to assist doctors with less oversight. The potential of AI to democratize access to healthcare is significant, but it requires robust regulatory frameworks to ensure safety and effectiveness.
Rapid Read Rapid Read
Israeli Scientists Develop First Genetic Atlas of Human Liver, Revealing Disease Vulnerabilities

Israeli Scientists Develop First Genetic Atlas of Human Liver, Revealing Disease Vulnerabilities

Scientists from the Weizmann Institute of Science, in collaboration with Sheba Medical Center and the Mayo Clinic, have created a detailed genetic atlas of the healthy human liver. Published in Nature, the study reveals a complex division of labor within the liver, identifying eight distinct regions with specific functions. This new understanding shows how certain areas of the liver are more susceptible to diseases like fatty liver disease. The research utilized advanced genetic mapping techniques and samples from healthy liver donors, providing unprecedented insights into liver function and disease vulnerability.
Rapid Read Rapid Read
AI's Role in Medicine: Balancing Innovation with Regulation

AI's Role in Medicine: Balancing Innovation with Regulation

A recent opinion piece highlights the transformative potential of artificial intelligence (AI) in democratizing healthcare access, particularly for underserved patients. The article discusses the rapid integration of AI in medical practices, where AI tools are increasingly used for routine prescriptions and minor medical conditions. However, the piece emphasizes the urgent need for robust regulation to ensure patient safety, as AI's role in medicine continues to expand. States like New York and California are taking different regulatory approaches, with New York considering legislation that could restrict AI's medical applications, while California mandates disclosure when AI is involved in patient care. The federal government is also involved, with the FDA updating its guidelines to allow certain AI tools to operate with less oversight when assisting doctors.
Rapid Read Rapid Read
Stanford Study Finds AI Enhances Physician Decision-Making in Clinical Management

Stanford Study Finds AI Enhances Physician Decision-Making in Clinical Management

A study led by Stanford Medicine has found that artificial intelligence (AI) can significantly enhance physician decision-making in clinical management. The research, led by Dr. Jonathan H. Chen, explored the use of AI-powered chatbots in assisting with complex medical decisions beyond diagnosis, such as treatment planning and care management. The study revealed that when physicians used AI as a decision support tool, their performance matched that of the AI alone, highlighting a synergistic relationship. This suggests that AI can complement human clinical judgment, leading to improved healthcare outcomes.